Numinus Wellness Inc.

TSX:NUMI.TO

0.025 (CAD) • At close November 4, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) CAD.

20232022202120202019201820172016
Revenue 23.186.4941.5140.8810.1072.81200
Cost of Revenue 14.8094.7171.5950.7930.36000
Gross Profit 8.3711.777-0.0820.088-0.2522.812-0-0
Gross Profit Ratio 0.3610.274-0.0540.1-2.349100
Reseach & Development Expenses 1.1681.8851.4010.1880.1480.11300
General & Administrative Expenses 30.5325.16811.696.0095.2692.36200
Selling & Marketing Expenses 1.9922.1922.2240.9060.190.04900
SG&A 32.52227.3613.9136.9155.4590.2510.2480.178
Other Expenses -0.5310.447-0.0340.06-0.081000
Operating Expenses 35.33130.22715.767.3576.080.2510.2480.178
Operating Income -27.481-28.004-15.876-7.277-6.399-0.252-0.248-0.178
Operating Income Ratio -1.186-4.312-10.488-8.259-59.541-0.08900
Total Other Income Expenses Net -2.547-15.908-2.819-2.196-0.885-0.028-0.011-1.8
Income Before Tax -30.256-44.916-18.774-9.601-7.269-0.279-0.26-1.978
Income Before Tax Ratio -1.305-6.916-12.403-10.895-67.631-0.09900
Income Tax Expense 0.229-0.0342.7842.2570.804-0-0-0
Net Income -30.256-44.882-18.774-9.601-7.269-0.279-0.26-1.978
Net Income Ratio -1.305-6.911-12.403-10.895-67.631-0.09900
EPS -0.11-0.21-0.11-0.15-2.52-0.13-0.12-1.1
EPS Diluted -0.11-0.21-0.11-0.15-2.52-0.13-0.12-1.1
EBITDA -24.647-26.498-15.159-6.587-5.874-0.251-0.248-0.178
EBITDA Ratio -1.063-4.08-10.014-7.475-54.654-0.08900